1. Home
  2. AVXL vs ITRN Comparison

AVXL vs ITRN Comparison

Compare AVXL & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • ITRN
  • Stock Information
  • Founded
  • AVXL 2004
  • ITRN 1994
  • Country
  • AVXL United States
  • ITRN Israel
  • Employees
  • AVXL N/A
  • ITRN N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • ITRN Electronic Components
  • Sector
  • AVXL Health Care
  • ITRN Technology
  • Exchange
  • AVXL Nasdaq
  • ITRN Nasdaq
  • Market Cap
  • AVXL 757.9M
  • ITRN 653.7M
  • IPO Year
  • AVXL N/A
  • ITRN 2005
  • Fundamental
  • Price
  • AVXL $8.37
  • ITRN $37.82
  • Analyst Decision
  • AVXL Strong Buy
  • ITRN Buy
  • Analyst Count
  • AVXL 2
  • ITRN 1
  • Target Price
  • AVXL $44.00
  • ITRN $50.00
  • AVG Volume (30 Days)
  • AVXL 703.8K
  • ITRN 70.0K
  • Earning Date
  • AVXL 05-13-2025
  • ITRN 05-28-2025
  • Dividend Yield
  • AVXL N/A
  • ITRN 5.30%
  • EPS Growth
  • AVXL N/A
  • ITRN 12.05
  • EPS
  • AVXL N/A
  • ITRN 2.70
  • Revenue
  • AVXL N/A
  • ITRN $336,257,000.00
  • Revenue This Year
  • AVXL N/A
  • ITRN $11.52
  • Revenue Next Year
  • AVXL N/A
  • ITRN $9.29
  • P/E Ratio
  • AVXL N/A
  • ITRN $14.03
  • Revenue Growth
  • AVXL N/A
  • ITRN 5.09
  • 52 Week Low
  • AVXL $3.51
  • ITRN $24.12
  • 52 Week High
  • AVXL $14.44
  • ITRN $45.43
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 44.23
  • ITRN 65.66
  • Support Level
  • AVXL $7.98
  • ITRN $34.56
  • Resistance Level
  • AVXL $8.68
  • ITRN $38.46
  • Average True Range (ATR)
  • AVXL 0.41
  • ITRN 1.01
  • MACD
  • AVXL -0.08
  • ITRN 0.36
  • Stochastic Oscillator
  • AVXL 23.31
  • ITRN 85.35

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products. The Telematics services segment consists of regionally- based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others.

Share on Social Networks: